Recent Analysts’ Ratings Changes for Celsius (CELH)

Celsius (NASDAQ: CELH) has recently received a number of price target changes and ratings updates:

• 4/1/2024 – Celsius had its price target raised by analysts at Maxim Group from $100.00 to $110.00. They now have a “buy” rating on the stock.
• 3/27/2024 – Celsius had its “equal weight” rating reaffirmed by analysts at Morgan Stanley. They now have a $75.00 price target on the stock.
• 3/18/2024 – Celsius had its price target raised by analysts at Stifel Europe from $90.00 to $95.00. They now have a “buy” rating on the stock.
• 3/18/2024 – Celsius had its price target raised by analysts at Jefferies Financial Group Inc. from $98.00 to $105.00. They now have a “buy” rating on the stock.
• 3/14/2024 – Celsius had its price target raised by analysts at Roth Mkm from $90.00 to $105.00. They now have a “buy” rating on the stock.
• 3/4/2024 – Celsius had its price target raised by analysts at Wedbush from $75.00 to $90.00. They now have an “outperform” rating on the stock.
• 3/1/2024 – Celsius had its price target raised by analysts at Piper Sandler from $76.00 to $90.00. They now have an “overweight” rating on the stock.
• 3/1/2024 – Celsius had its price target raised by analysts at Morgan Stanley from $65.00 to $75.00. They now have an “equal weight” rating on the stock.
• 3/1/2024 – Celsius had its price target raised by analysts at UBS Group AG from $73.00 to $99.00. They now have a “buy” rating on the stock.
• 3/1/2024 – Celsius had its price target raised by analysts at Stifel Nicolaus from $67.00 to $90.00. They now have a “buy” rating on the stock.
• 3/1/2024 – Celsius had its price target raised by analysts at Maxim Group from $65.00 to $100.00. They now have a “buy” rating on the stock.
• 2/27/2024 – Celsius had its “outperform” rating reaffirmed by analysts at Wedbush. They now have a $90.00 price target on the stock, up previously from $75.00.
• 2/16/2024 – Celsius had its price target raised by analysts at Stifel Nicolaus from $64.00 to $67.00. They now have a “buy” rating on the stock.

Celsius Trading Up 4.0 %

Shares of CELH stock traded up $3.10 on Thursday, hitting $79.75. 3,550,411 shares of the stock were exchanged, compared to its average volume of 4,918,543. Celsius Holdings, Inc. has a one year low of $28.08 and a one year high of $99.62. The firm’s 50 day moving average is $73.08 and its two-hundred day moving average is $62.60. The firm has a market capitalization of $18.42 billion, a PE ratio of 103.13, a P/E/G ratio of 2.31 and a beta of 1.86.

Celsius (NASDAQ:CELH) last announced its quarterly earnings data on Thursday, February 29th. The company reported $0.17 earnings per share for the quarter, beating analysts’ consensus estimates of $0.16 by $0.01. The company had revenue of $347.44 million for the quarter, compared to analysts’ expectations of $326.77 million. Celsius had a return on equity of 131.58% and a net margin of 17.21%. Celsius’s revenue for the quarter was up 95.2% compared to the same quarter last year. During the same period last year, the firm posted $0.01 EPS. On average, sell-side analysts expect that Celsius Holdings, Inc. will post 1.09 earnings per share for the current year.

Insider Transactions at Celsius

In other Celsius news, Director Caroline S. Levy sold 20,000 shares of the business’s stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $94.77, for a total value of $1,895,400.00. Following the sale, the director now directly owns 37,891 shares of the company’s stock, valued at $3,590,930.07. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other Celsius news, Director Nicholas Castaldo sold 165,000 shares of the business’s stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $83.33, for a total transaction of $13,749,450.00. Following the completion of the sale, the director now owns 352,864 shares of the company’s stock, valued at $29,404,157.12. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Caroline S. Levy sold 20,000 shares of the business’s stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $94.77, for a total value of $1,895,400.00. Following the sale, the director now directly owns 37,891 shares of the company’s stock, valued at approximately $3,590,930.07. The disclosure for this sale can be found here. In the last three months, insiders have sold 1,094,783 shares of company stock worth $62,679,671. 2.70% of the stock is currently owned by insiders.

Institutional Trading of Celsius

Several institutional investors have recently made changes to their positions in the business. Cary Street Partners Investment Advisory LLC lifted its stake in shares of Celsius by 1,350.0% in the 3rd quarter. Cary Street Partners Investment Advisory LLC now owns 145 shares of the company’s stock valued at $25,000 after purchasing an additional 135 shares during the last quarter. Contravisory Investment Management Inc. bought a new stake in Celsius during the 4th quarter valued at $25,000. Transcendent Capital Group LLC purchased a new position in shares of Celsius in the 4th quarter valued at $25,000. Money Concepts Capital Corp purchased a new position in shares of Celsius in the 4th quarter valued at $28,000. Finally, Tidemark LLC purchased a new position in shares of Celsius in the 4th quarter valued at $29,000. Hedge funds and other institutional investors own 60.95% of the company’s stock.

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.